"Scientists at the National Institutes of Health report they have discovered in mouse studies that a small molecule released in the spinal cord triggers a process that is later experienced in the brain as the sensation of itch.
In another clinical study, a dose of 3.2 mg/kg administered intravenously (approximately 8 times the therapeutic dose for HAE) caused erythema, itching and hypotension in healthy subjects. No therapeutic intervention was necessary.
Last reviewed on RxList: 9/1/2011
This monograph has been modified to include the generic and brand name in many instances.
Additional Firazyr Information
Report Problems to the Food and Drug Administration
Find out what women really need.